ALKBH5 drives glycolysis in resistant breast cancer cells by mediating YTHDF2-dependent m6A demethylation of GLUT4 mRNA, which stabilizes the transcript and enhances glucose metabolism [84]. Here, YTHDF2 is linked to breast cancer.